跳至主要内容
临床试验/NCT03428581
NCT03428581终止不适用

Preventing Lymphedema in Patients Undergoing Axillary Lymph Node Dissection Via Axillary Reverse Mapping and Lympho-venous Bypass

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 264 人开始时间: 2018年4月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
264
试验地点
2
主要终点
Less frequently reported symptoms of lymphedema in the study extremity compared to baseline and the control extremity

研究概览

简要总结

The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.

详细描述

All subjects will undergo an axillary lymph node dissection (ALND). Cluster randomization will determine which of these subjects will have the ARM with LVB and which subjects will have the ALND without this technique. As a baseline, all subjects will have the circumference of their arms measured and complete a questionnaire about lymphedema. Performing the measurements and answering a questionnaire will be repeated at 6, 12, 24, and 36 months after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients scheduled to undergo an axillary lymph node dissection
  • Patients who in the surgeon's judgement are at high risk to convert to an axillary lymph node dissection based intraoperative findings
  • English speaking

排除标准

  • Prior ipsilateral axillary lymph node dissection
  • Prior ipsilateral axillary radiation
  • Patients undergoing sentinel lymph node biopsy only or at low risk of converting to an axillary lymph node dissection in the surgeon's judgement
  • Previous treatment for lymphedema of either arm or prescribed prophylactic treatment for lymphedema.
  • Pregnant patients cannot participate in the substudy

研究组 & 干预措施

ALND with ARM +/- LVB

Experimental

Axillary Lymph Node Dissection (ALND) using Axillary Reverse Mapping (ARM) with Lympho-venous bypass (LVB) will be performed.

干预措施: ALND with ARM +/- LVB (Procedure)

ALND without ARM +/- LVB

Active Comparator

Axillary Lymph Node Dissection (ALND)

干预措施: ALND (Procedure)

结局指标

主要结局

Less frequently reported symptoms of lymphedema in the study extremity compared to baseline and the control extremity

时间窗: 36 months following surgery

Validated patient reported surveys

Less than 5% limb volume increase in the study extremity compared to baseline and the control extremity

时间窗: 36 months following surgery

Bilateral Limb volume measurements

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

James W. Jakub

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验